Human herpesvirus‐8‐related Kaposi's sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin

: The iatrogenic form of Kaposi's sarcoma (KS) is typically observed among transplant recipients, and the most appropriate therapeutic approach (usually including reduction of immunosuppression, specific chemotherapy, and/or administration of antiviral agents against human herpes virus‐8) is st...

Full description

Saved in:

Bibliographic Details
Published in:	Transplant infectious disease Vol. 7; no. 1; pp. 34 - 37
Main Authors:	Verucchi, G., Calza, L., Trevisani, F., Zambruni, A., Tadolini, M., Giuliani, R., Manfredi, R., Andreone, P., Chiodo, F., Bernardi, M.
Format:	Journal Article
Language:	English
Published:	Oxford, UK Munksgaard International Publishers 01.03.2005
Subjects:	Antibiotics, Antineoplastic - therapeutic use Antiviral Agents - therapeutic use cidofovir Cytosine - analogs & derivatives Cytosine - therapeutic use daunorubicin Daunorubicin - therapeutic use Drug Therapy, Combination Herpesvirus 8, Human - isolation & purification human herpes virus‐8 Humans Immunocompromised Host Kaposi's sarcoma liver transplantation Liver Transplantation - adverse effects Male Middle Aged Organophosphonates - therapeutic use Sarcoma, Kaposi - drug therapy Sarcoma, Kaposi - virology Viral Load Viremia
ISSN:	1398-2273, 1399-3062
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!